Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

67147 Press Releases
DateTitleCompany
26 Jul 12 ArQule to Report Second Quarter 2012 Financial Results on August 2, 2012 ArQule Inc.,
Published by
Business Wire
26 Jul 12 Histogenics Selects ImageIQ to Provide Imaging Analysis for Phase 3 Clinical Trial ImageIQ Inc.,
Published by
Business Wire
26 Jul 12 Author Describes and Explains Everything About Pain in New Book ERELEASES,
Published by
PR Newswire
26 Jul 12 Bill O'Reilly's Influence Proves Invaluable to Small Businesses WESTERN CREATIVE INC.,
Published by
PR Newswire
26 Jul 12 Research and Markets: Insulin Resistance - Pipeline Review, H1 2012 Research and Markets,
Published by
Business Wire
26 Jul 12 Exelixis Announces Initiation of Cabozantinib Investigator-Sponsored Trials in Non-Small Cell Lung Cancer and Multiple Myeloma Exelixis Inc.,
Published by
Business Wire
26 Jul 12 Safeguard Scientifics Announces Second Quarter 2012 Financial Results Safeguard Scientifics Inc.,
Published by
Business Wire
26 Jul 12 Covidien Reports Third-Quarter Results Covidien,
Published by
Business Wire
26 Jul 12 AVEO Oncology Announces Timing for Second Quarter Financial Results, Webcast and Conference Call AVEO Oncology,
Published by
Business Wire
26 Jul 12 Faces of China Showcased in London PRN ASIA,
Published by
PR Newswire
26 Jul 12 Apogenix GmbH: APG101 Exceeds Expectations with Controlled Phase II Clinical Trial in Treatment of Recurrent Glioblastoma Apogenix GmbH,
Published by
Business Wire
26 Jul 12 Sanofi CEO Chris Viehbacher Comments on Results for Q2 2012 Sanofi,
Published by
Business Wire
26 Jul 12 XenoPort Announces Pricing of Public Offering of Common Stock XenoPort Inc.,
Published by
Business Wire
26 Jul 12 SurModics to Webcast Third Quarter 2012 Earnings Conference Call on August 1st SurModics Inc.,
Published by
Business Wire
26 Jul 12 Matrix Medical Network to Provide Medicare Advantage Home Assessment Services for Humana Matrix Medical Network,
Published by
Business Wire
26 Jul 12 XenoPort Announces Proposed Public Offering of Common Stock XenoPort Inc.,
Published by
Business Wire
26 Jul 12 Greatbatch, Inc. Reports 2012 Second Quarter Results Greatbatch Inc.,
Published by
Business Wire
26 Jul 12 Merck, Collaborators Publish Study Showing Potential for Eradication of Persistent HIV Virus in the Body Merck,
Published by
Business Wire
26 Jul 12 Bard Announces Enrollment Completion of First Ever IDE-Approved Drug-Coated Balloon Clinical Trial and Initiation of Large Continuation Registry Study C. R. Bard Inc.,
Published by
Business Wire
26 Jul 12 Bard Announces Second Quarter Results C. R. Bard Inc.,
Published by
Business Wire
26 Jul 12 National Coalition of Pharmaceutical Distributors Expert Addresses U.S. Senate Committee on Value of Small Distributors in Health Care National Coalition of Pharmaceutical Distributors,
Published by
Business Wire
26 Jul 12 2012 International AIDS Conference uses Conference Compass technology to help attendees maximize their productivity Conference Compass,
Published by
Business Wire
26 Jul 12 Over 1,000 Industry Leaders to Attend Licensing Executives Society (U.S.A. and Canada) Annual Meeting October 14-17 in Toronto to Stay Current Amid the IP Evolution Licensing Executives Society (U.S.A. and Canada) Inc.,
Published by
Business Wire
26 Jul 12 Bio-Path Holdings Begins Enrollment in Fourth Cohort of Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemias Bio-Path Holdings Inc.,
Published by
Business Wire
26 Jul 12 Half Year 2012 results and R&D highlights: DBV Technologies on track DBV Technologies,
Published by
Business Wire
26 Jul 12 Maxwell Biotech Venture Fund’s Portfolio Company, Infectex, Receives Russian Regulator’s Approval to Conduct Pivotal Clinical Trial for Sequella’s Antibiotic, SQ109, for Tuberculosis Sequella,
Published by
Business Wire
25 Jul 12 Austin Recovery and St. David's Foundation Continue Partnership to Help Central Texans AUSTIN RECOVERY,
Published by
PR Newswire
25 Jul 12 Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results NEUROCRINE BIOSCIENCES INC.,
Published by
PR Newswire
25 Jul 12 Superior Efficacy Will Propel Vivus’s Qsymia to Become the Most Widely Used Emerging Therapy for the Treatment of Obese or Overweight Patients Decision Resources,
Published by
Business Wire
25 Jul 12 AJWS Haitian Grantee Wins U.N. Red Ribbon Award for HIV Prevention American Jewish World Service,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.